期刊文献+

白细胞介素1受体拮抗剂对豚鼠哮喘的作用 被引量:1

EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST ON EXPERIMENTAL ASTHMA IN GUINEA-PIGS
下载PDF
导出
摘要 从整体角度研究白介素1受体拮抗剂(IL-1ra)的抗哮喘作用及对豚鼠离体气管平滑肌活动的影响。结果表明:整体状态下,IL-1ra用量为0.25~4.0mg·kg^(-1)时,能剂量依赖性地延长组织防-乙酰胆碱(His-Ach)诱发的豚鼠哮喘潜伏期,降低动物跌倒率;离体试验时,IL-1ra浓度高于10^(-9)mol·L^(-1)对气管平滑肌具有直接松弛作用,EC_(50)为8.06×10^(-3)mol·L^(-1);当浓度高于10^(-7)mol·L^(-1)时,能对抗His、Ach及5-羟色胺(5-HT)引起气管平滑肌肌张力增加;当浓度为10^(-7)~10^(-3)mol·L^(-1)时,预防给药能抑制His诱发气管平滑肌收缩,最大收缩效应降低,并可对抗Ach及5-HT对气管平滑肌的兴奋作用,但当其浓度低于10^(-6)mol·L^(-1)时,效应相反。 The anti-effects of interleukin-1 receptor antagonist (IL-lra) on asthma and isolated guinea-pig trachea smooth muscle contraction in vivo and in vitro was described. The results showed that in the dose of 0. 25 - 4. 0 mg · kg-1, IL-lra could prolong the asthmatic incubation period , and reduce animal tumble ratio in asthmatic guinea-pig induced by histamine-acetylcholine. These effects were dose-dependent. In vitro > IL-lra could directly relax trachea smooth muscles at the dose of 10-9 mol · L-1, its EC50 value was 8. 06×10-8mol · L-1, and it could antagonize the increase of trachea tension stimulated by His, Ach and 5-hydroxytryptamine (5-HT) above the dose of 10-7 mol · L-1. IL-lra could also prevent contraction of trachea smooth muscles induced by His at the dose of 10-7 - 10-8 mol · L-1, its maximal effects decreased. Moreover IL-lra could antagonize trachea smooth muscles excitation induced by Ach or 5-HT between 10-7-10-3mol · L-1, but it might have the reverse effects under the dose of 10-9 mol · L-1.
出处 《扬州大学学报(农业与生命科学版)》 CAS CSCD 2003年第3期19-22,共4页 Journal of Yangzhou University:Agricultural and Life Science Edition
基金 国家高技术研究发展计划项目(863-2001AA215251)
关键词 豚鼠 白细胞介素1受体拮抗剂 哮喘 气管平滑肌 guinea-pig interleukin receptor antagonist asthma tracheasmooth muscle
  • 相关文献

参考文献15

  • 1中华人民共和国卫生部药政局.呼吸系统药物药效学研究指导原则[A]..新药(西药)临床前研究指导原则汇编(药学,药理学,毒理学)[C].北京:中华人民共和国卫生部药政局,1993.79.
  • 2Peter J B. Cytokine modulators as novel therapies for asthma []]. Annu Rev Pharmacol Toxicol, 2002, 42 : 81-98.
  • 3Hakonarson H, Halapi E, Whelan R, et al. Association between IL-1 beta/TNF-alpha-induced glucocorticoid - sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle [J]. Am J Respir Cell Mol Biol, 2001, 25: 761-771.
  • 4Amici D M, Puggioni F, Casali L, et al. Variations in serum levels of interleukin (IL)-lbeta, IL-2, IL-6, and tumor necrosis factor-alpha during specific immunotherapy [J]. Ann Allergy Asthma Immunol, 2001, 86: 311-313.
  • 5Hagaman D D, Okayama Y D, Ambrosio C, et al. Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglohulin E-mediated activation and after segmental antigen challenge [J]. Am J Respir Cell Mol Biol, 2001, 25: 685-691.
  • 6Tillie-Leblond I, Pugin J, Marquette C H, et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus [J]. Am J Respir Crit Care Med, 1999, 159: 487-494.
  • 7Mao X Q, Kawai M, Yamashita T, et al. Imbalance production between interleukin-1 bata (IL-1 beta) and IL-1 receptor antagonist (IL-lra) in bronchialasthma [J]. Biochem Biophys Res Commun, 2000, 276: 607-612.
  • 8Rosenwasser L J. New immunopharmacologic approaches to asthma: role of cytokine antagonism [J]. J Allergy Clin Immunol, 2000, 105: 586-591.
  • 9Ricci M, Matucci A, Rossi O. New advances in the pathogenesis and therapy of bronchial asthma [J]. Ann Ital Med Int,1998, 13: 93-110.
  • 10Ghaffar O, Hamid Q, Renzi P M, et al. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells [J]. Am J Respir Crit Care Med, 1999, 159: 1933-1942.

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部